GlaxoSmithKline (GSK) continues to be the market leader in consumer health. While its strength remains in analgesics, digestive remedies, and vitamins and dietary supplements, the lack of a strong allergy remedy portfolio hurt the recovery of cough, cold and allergy remedies in 2021. The business witnessed its fastest growth in 2021 in Middle East and Africa, followed by Asia Pacific. Supported by its powerbrands, the business will be spun off as a separate consumer health entity in 2022.
Files are delivered directly into your account soon after payment is received and any tax certification is verified (where applicable).
Euromonitor International's report on GlaxoSmithKline Plc delivers a detailed strategic analysis of the company's business, examining its performance in the Consumer Health market and the global economy. Company and market share data provide a detailed look at the financial position of GlaxoSmithKline Plc, while in-depth qualitative analysis will help you understand the brand strategy and growth prospects of GlaxoSmithKline Plc.
Euromonitor International's company profile reports are written by our Consumer Health research team, a dedicated group of analysts that knows the industry inside and out. Buy this report to inform your planning, strategy, marketing, sales and competitor intelligence functions.
Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Home Page